Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Identification of transferrin receptor 1 as a hepatitis C virus entry factor.

Martin DN, Uprichard SL.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10777-82. doi: 10.1073/pnas.1301764110. Epub 2013 Jun 10.

2.

CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.

Ishibashi M, Morita N, Nomura-Kawaguchi C, Shimizu Y, Wakita T, Esumi M.

Arch Virol. 2014 Nov;159(11):2949-55. doi: 10.1007/s00705-014-2150-z. Epub 2014 Jun 26.

PMID:
24965233
3.

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

Haberstroh A, Schnober EK, Zeisel MB, Carolla P, Barth H, Blum HE, Cosset FL, Koutsoudakis G, Bartenschlager R, Union A, Depla E, Owsianka A, Patel AH, Schuster C, Stoll-Keller F, Doffoël M, Dreux M, Baumert TF.

Gastroenterology. 2008 Nov;135(5):1719-1728.e1. doi: 10.1053/j.gastro.2008.07.018. Epub 2008 Jul 22.

PMID:
18718838
4.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM.

Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.

5.

Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.

Qin ZL, Ju HP, Gao TT, Wang WB, Ren H, Zhao P, Qi ZT.

J Gen Virol. 2015 Jun;96(Pt 6):1389-99. doi: 10.1099/vir.0.000091. Epub 2015 Feb 20.

PMID:
25701820
6.

The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.

Herbison CE, Thorstensen K, Chua AC, Graham RM, Leedman P, Olynyk JK, Trinder D.

Am J Physiol Cell Physiol. 2009 Dec;297(6):C1567-75. doi: 10.1152/ajpcell.00649.2008. Epub 2009 Oct 14.

7.

Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Tong Y, Zhu Y, Xia X, Liu Y, Feng Y, Hua X, Chen Z, Ding H, Gao L, Wang Y, Feitelson MA, Zhao P, Qi ZT.

J Virol. 2011 Mar;85(6):2793-802. doi: 10.1128/JVI.01818-10. Epub 2010 Dec 22.

8.

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset FL, Wakita T, Jaeck D, Doffoel M, Royer C, Soulier E, Schvoerer E, Schuster C, Stoll-Keller F, Bartenschlager R, Pietschmann T, Barth H, Baumert TF.

Hepatology. 2007 Dec;46(6):1722-31.

9.

Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.

Ashfaq UA, Qasim M, Yousaf MZ, Awan MT, Jahan S.

J Transl Med. 2011 Nov 10;9:194. doi: 10.1186/1479-5876-9-194.

10.

Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.

Tran SC, Pham TM, Nguyen LN, Park EM, Lim YS, Hwang SB.

J Virol. 2016 Jul 27;90(16):7231-7247. doi: 10.1128/JVI.00326-16. Print 2016 Aug 15.

11.

Pim Kinase Interacts with Nonstructural 5A Protein and Regulates Hepatitis C Virus Entry.

Park C, Min S, Park EM, Lim YS, Kang S, Suzuki T, Shin EC, Hwang SB.

J Virol. 2015 Oct;89(19):10073-86. doi: 10.1128/JVI.01707-15. Epub 2015 Jul 22.

12.

Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.

Diao J, Pantua H, Ngu H, Komuves L, Diehl L, Schaefer G, Kapadia SB.

J Virol. 2012 Oct;86(20):10935-49. Epub 2012 Aug 1.

13.

CD81 and hepatitis C virus (HCV) infection.

Fénéant L, Levy S, Cocquerel L.

Viruses. 2014 Feb 6;6(2):535-72. doi: 10.3390/v6020535. Review.

14.

CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF.

Viruses. 2014 Feb 18;6(2):875-92. doi: 10.3390/v6020875. Review.

15.

Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.

Deest M, Westhaus S, Steinmann E, Manns MP, von Hahn T, Ciesek S.

Antiviral Res. 2014 Jan;101:37-44. doi: 10.1016/j.antiviral.2013.10.018. Epub 2013 Nov 7.

PMID:
24211330
16.

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA.

J Virol. 2004 Feb;78(3):1448-55.

17.

The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T.

J Virol. 2007 Jan;81(2):588-98. Epub 2006 Nov 1.

18.

Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.

Zhang F, Sodroski C, Cha H, Li Q, Liang TJ.

Gastroenterology. 2017 Jan;152(1):257-270.e7. doi: 10.1053/j.gastro.2016.09.033. Epub 2016 Sep 30.

19.

Diverse CD81 proteins support hepatitis C virus infection.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA.

J Virol. 2006 Nov;80(22):11331-42. Epub 2006 Aug 30.

20.

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, Narbus CM, Parra Martín A, Evans MJ.

PLoS Pathog. 2013 Mar;9(3):e1003244. doi: 10.1371/journal.ppat.1003244. Epub 2013 Mar 21.

Supplemental Content

Support Center